Procter & Gamble Health Ltd
NSE:PGHL

Watchlist Manager
Procter & Gamble Health Ltd Logo
Procter & Gamble Health Ltd
NSE:PGHL
Watchlist
Price: 5 579 INR -0.45% Market Closed
Market Cap: 92.6B INR

Intrinsic Value

The intrinsic value of one PGHL stock under the Base Case scenario is 3 082.37 INR. Compared to the current market price of 5 579 INR, Procter & Gamble Health Ltd is Overvalued by 45%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PGHL Intrinsic Value
3 082.37 INR
Overvaluation 45%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Procter & Gamble Health Ltd

Valuation History Unavailable

Historical valuation for PGHL cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Procter & Gamble Health Ltd
NSE:PGHL
IN
Pharmaceuticals
Market Cap
92.6B INR
IPO
Nov 21, 1993
IN
Pharmaceuticals
Market Cap
92.6B INR
IPO
Nov 21, 1993
Price
₹false
EPS
₹false
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PGHL?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Procter & Gamble Health Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Procter & Gamble Health Ltd

Current Assets 6.1B
Cash & Short-Term Investments 2.9B
Receivables 1.3B
Other Current Assets 1.9B
Non-Current Assets 2.6B
Long-Term Investments 17.3m
PP&E 1.3B
Intangibles 8.4m
Other Non-Current Assets 1.3B
Efficiency

Free Cash Flow Analysis
Procter & Gamble Health Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Procter & Gamble Health Ltd

Revenue
11.6B INR
Cost of Revenue
-3.2B INR
Gross Profit
8.4B INR
Operating Expenses
-5.4B INR
Operating Income
3.1B INR
Other Expenses
-710.8m INR
Net Income
2.4B INR
Fundamental Scores

PGHL Profitability Score
Profitability Due Diligence

Procter & Gamble Health Ltd's profitability score is 75/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Exceptional 3-Year Average ROE
Exceptional ROIC
75/100
Profitability
Score

Procter & Gamble Health Ltd's profitability score is 75/100. The higher the profitability score, the more profitable the company is.

PGHL Solvency Score
Solvency Due Diligence

Procter & Gamble Health Ltd's solvency score is 83/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Long-Term Solvency
83/100
Solvency
Score

Procter & Gamble Health Ltd's solvency score is 83/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PGHL Price Targets Summary
Procter & Gamble Health Ltd

There are no price targets for PGHL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PGHL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

PGHL Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one PGHL stock?

The intrinsic value of one PGHL stock under the Base Case scenario is 3 082.37 INR.

Is PGHL stock undervalued or overvalued?

Compared to the current market price of 5 579 INR, Procter & Gamble Health Ltd is Overvalued by 45%.

Back to Top